HH
HZNP

Hilltop Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Hilltop Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,950
Closed -$235K – 567
2022
Q2 		$235K Sell
2,950
-39
-1% -$3.69K 0.03% 443
2022
Q1 		$314K Buy
2,989
+205
+7% +$20K 0.04% 417
2021
Q4 		$300K Buy
2,784
+383
+16% +$41.8K 0.03% 471
2021
Q3 		$263K Sell
2,401
-100
-4% -$10.4K 0.03% 514
2021
Q2 		$234K Buy
+2,501
New +$230K 0.03% 518

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Hilltop Holdings's HZNP Position: Q3 2022 in Review

Hilltop Holdings sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 2,950 shares — an estimated $235K sold.

Hilltop Holdings first reported a position in HZNP in Q2 2021 and held it in 5 quarters. The position peaked at $314K in Q1 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • Hilltop Holdings reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Hilltop Holdings sold 2,950 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $235K.
  • Hilltop Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 5 quarters.
  • Hilltop Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $314K in Q1 2022.
  • 530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Hilltop Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.